Skip to content
PubMed This is a summary of 62 peer-reviewed journal articles Updated
Allergy

Indolent Systemic Mastocytosis (ISM) Resource Guide

At a Glance

Indolent Systemic Mastocytosis (ISM) is a slow-moving, rare disease where the body produces too many mast cells. While it causes daily allergy-like symptoms, it generally does not cause organ damage, and most patients have a normal life expectancy. Treatment focuses on symptom management.

Welcome to the resource guide for Indolent Systemic Mastocytosis (ISM).

Systemic mastocytosis is a rare condition where your body produces an abnormally high number of mast cells—cells that play a critical role in your immune system and allergic responses. “Indolent” means that the disease is slow-moving and generally stable. While it can cause a high burden of daily symptoms due to the chemicals these cells release, it does not typically cause organ failure, and most patients have a normal life expectancy.

This guide is designed to empower you with the knowledge you need to understand your diagnosis, communicate effectively with your care team, and take charge of your daily health.

Guide Contents

Common questions in this guide

What does 'indolent' mean in systemic mastocytosis?
In systemic mastocytosis, 'indolent' means the disease is slow-moving and stable. While it can cause a high burden of daily symptoms due to the chemicals mast cells release, it does not typically cause organ failure, and most patients have a normal life expectancy.
Which specialists treat Indolent Systemic Mastocytosis?
Because ISM affects multiple systems in the body, care usually requires a multidisciplinary approach. A core care team typically includes an allergist or immunologist, a hematologist, and often a gastroenterologist.
What is the KIT mutation in ISM?
The KIT D816V mutation is a specific genetic change commonly found in patients with systemic mastocytosis. It drives the body to produce an abnormally high number of mast cells and is a key part of the WHO diagnostic criteria.
How is ISM different from Mast Cell Activation Syndrome (MCAS)?
While both conditions involve mast cell reactions, ISM is diagnosed when there is a physical overproduction of mast cells, usually driven by a genetic mutation. Your doctor will use specific WHO criteria and pathology tests to differentiate ISM from MCAS.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with Indolent Systemic Mastocytosis do you currently treat, and what is your experience with this condition?
  2. 2.Which specialists should be included in my core care team (e.g., allergist, hematologist, gastroenterologist)?
  3. 3.How often should we schedule routine follow-up appointments to monitor my disease?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

This guide provides educational information about Indolent Systemic Mastocytosis (ISM). Always consult your hematologist or allergist to discuss your specific symptoms, test results, and treatment plan.

Get notified when new evidence is published on Indolent systemic mastocytosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.